Search Lavipharm.com

 

Author: maria

  • All
  • Announcements
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Share Capital Increase
  • Uncategorized
  • Διανομή Μερίσματος

Peania, May 10th 2021 - It is with great sadness that the family of Lavipharm bids farewell to Athanase (Thanassis) Lavidas, Executive Chairman, who passed away on Saturday, May 8, 2021, at the age of 73. Athanase Lavidas was Lavipharm’s majority shareholder leading the company since 1976. Under...

Παιανία, 10 Μαΐου 2021 - Η Lavipharm A.E. ανακοινώνει ότι, μετά την αναγγελία του αναπάντεχου και θλιβερού γεγονότος του θανάτου του Προέδρου της Εταιρείας Αθανασίου Λαβίδα, το Διοικητικό Συμβούλιο σύσσωμο αποφάσισε να συνεχίσει τη διαχείριση και εκπροσώπηση της Εταιρείας χωρίς την αντικατάσταση του ελλείποντος, καθώς...

[video width="960" height="540" mp4="http://lavipharm.com/wp-content/uploads/2020/12/2021.mp4" poster="http://lavipharm.com/wp-content/uploads/2020/12/lavipharm2021.jpg"][/video]...

Peania, April 3rd, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, March 27th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, March 20th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, March 13th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase Lavidas, proceeded...

Peania, March 6th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, February 28th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, February 21st, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...